Wednesday, November 13, 2024
spot_img
spot_img
HomeNewsCaribbean NewsWHO drops hydroxychloroquine from solidarity trial 

WHO drops hydroxychloroquine from solidarity trial 

GENEVA, Switzerland — World Health Organization (WHO) has announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped.

The trial’s executive group and principal investigators made the decision based on evidence from the Solidarity Trial, UK’s Recovery trial, and a Cochrane review of other evidence on hydroxychloroquine.

Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UKs Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician.

This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre- or post-exposure prophylaxis in patients exposed to COVID-19.

spot_img
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img
spot_img
spot_img

Caribbean News

US grounds all flights to Haiti for 30 days after planes hit by gunfire

- The US Federal Aviation Administration (FAA) has ordered the cancellation of all flights to Haiti for a month after two jets of US airline companies were hit...

Global News

IsDB joins efforts with WHO and development partners to promote health impact investment

BAKU / SWITZERLAND - As part of its commitment to the global initiative to build stronger primary health care and health systems resilience, the...